Skip to content

P&R Bidco

Active
Private limited companyfounded 2022active for 4 yearsWetenschapspark 5, 3590 Diepenbeek, BelgiumKBO/BCE: BE 0784.660.219
Summary

P&R Bidco has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12.3m and a net result of €4.4m. Equity is growing by about 6% per year across the filed financial years. Its solvency ranks better than 95% of 9,787 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
Largest company by total assets in Diepenbeek, Wholesale and retail trade sector1 site
Size
€12.7mtotal assets 2025
Equity
€12.3m
Profit
€4.4m
Turnover not published (abbreviated format)
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
ILC NEWCO IV BV
Holdings
1
  • ILC Newco IV B.V.Director · permanent representative Peter Segers
2025 accounts 10 days early2 of 4 deeds summarised
Why 94raises riskLiquidity: current ratio 0.96, cash €389,192Founded in 2022lowers riskSize: total assets €12.7mFigures for financial year 2025 (filed 21-07-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 92% of its sector peers (NACE 46, medium-sized)
Financial strength · tick = 2024
Strong
Solvency 100+11
equity 96.8% of total assets
Liquidity 54+5
short-term debt 3.2% · cash 3.1%
Profitability 100+65
return on assets 34.5%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (746 companies, NACE 46, medium-sized)
Last 24 months 11-2024: 1.3%highest value 12-2024: 1.3%● unchanged vs 11-2024highest value 01-2025: 1.2%▼ -0.1 percentage points vs 12-2024 02-2025: 1.2%● unchanged vs 01-2025 03-2025: 1.2%● unchanged vs 02-2025 04-2025: 1.2%● unchanged vs 03-2025 05-2025: 1.2%● unchanged vs 04-2025 06-2025: 1.3%▲ +0.1 percentage points vs 05-2025 07-2025: 1.3%● unchanged vs 06-2025 08-2025: 0.7%▼ -0.6 percentage points vs 07-2025 09-2025: 0.7%● unchanged vs 08-2025 10-2025: 0.7%● unchanged vs 09-2025 11-2025: 0.7%● unchanged vs 10-2025 12-2025: 0.6%▼ -0.1 percentage points vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.6%● unchanged vs 04-2026 06-2026: 0.7%▲ +0.1 percentage points vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 0.2%▼ -0.5 percentage points vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €1,150,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.96, compared with 0.02 in 2024, below 1; short-term debt: 3.2% and cash: 3.1% of total assets), and 3.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized): better than 93% on solvency, 81% on liquidity, 99% on profitability and 94% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 0.96, cash €389,192
NBB · annual accounts
raises risk · Founded in 2022
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: total assets €12.7m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 21-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-07-2026, 10 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
10 days early
2024
29 days early
2023
153 days early
2022
20 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 53 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Back to profitnet €4.4m
  3. Equity above €10mequity €12.3m ▲55.4%

Key points

  • Positive: Back in profit in 2025after -€134,187 in 2024 €4.4m View
  • Positive: Largest company by total assets in Diepenbeek, Wholesale and retail trade sectorin the Checked rankings No. 1 View
  • Controlled by ILC NEWCO IV BVthe company in turn controls 1 companies parent View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Total assets
€12.7m
Profit
€4.4m
Solvency
96.8%
Total assets▲ 2.9%
Net result
20222025
Go to Financials

Timeline

Events
9
Since
2023
Next accounts
by 31-07-2027
  1. 02-07-2025Annual accounts filed
  2. 20-06-2024Purpose · Amendment of the articles
  3. 29-02-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
08-04-2022
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about P&R Bidco

What is the company number of P&R Bidco?
0784.660.219. In Belgium the VAT number is the company number with BE in front: BE 0784.660.219.
Where is P&R Bidco based?
The registered office is at Wetenschapspark 5, 3590 Diepenbeek.Company details
What does P&R Bidco do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of P&R Bidco?
Private limited company (BV).
When was P&R Bidco founded?
On 08-04-2022.
Is P&R Bidco still active?
Yes, P&R Bidco is an active enterprise in the KBO register.
What is the turnover of P&R Bidco?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is P&R Bidco profitable?
In financial year 2025, P&R Bidco made a profit of €4.4m.
Where can I find the annual accounts of P&R Bidco?
P&R Bidco filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of P&R Bidco due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to P&R Bidco

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.